Is Korea Prepared for an Alzheimer’s Disease-Modifying Therapy? Assessing the Korean Healthcare System Infrastructure and the Effect of Blood-Based Biomarker Tests
Hankyung Jun, Sang Kyu Cho, Joanne Yoong, Soeren Mattke
Ann Geriatr Med Res. 2021;25(1):33-38.   Published online 2021 Feb 4     DOI: https://doi.org/10.4235/agmr.20.0082
Citations to this article as recorded by Crossref logo
Early onset diagnosis in Alzheimer’s disease patients via amyloid-β oligomers-sensing probe in cerebrospinal fluid
Jusung An, Kyeonghwan Kim, Ho Jae Lim, Hye Yun Kim, Jinwoo Shin, InWook Park, Illhwan Cho, Hyeong Yun Kim, Sunghoon Kim, Catriona McLean, Kyu Yeong Choi, YoungSoo Kim, Kun Ho Lee, Jong Seung Kim
Nature Communications.2024;[Epub]     CrossRef
The path to next-generation disease-modifying immunomodulatory combination therapies in Alzheimer’s disease
Marie Sarazin, Julien Lagarde, Inès El Haddad, Leonardo Cruz de Souza, Bertrand Bellier, Marie-Claude Potier, Michel Bottlaender, Guillaume Dorothée
Nature Aging.2024; 4(6): 761.     CrossRef
Framing influence of emotions and attitudes towards Alzheimer’s disease on Slovak and Spanish laypersons: a cross-cultural approach
Fátima Cuadrado, Lucia Lackova, Marina Mikulajová, Adoración Antolí, Veronika Boleková, Michal Gellen, Julia Vacas
Humanities and Social Sciences Communications.2023;[Epub]     CrossRef